DRREDDY's weekly performance was disappointing, with a return of -0.58%, indicating a decline in stock value. The stock's volatility was relatively moderate at 11.73%, but its Sharpe Ratio of -0.19 suggests that the return was not sufficient to compensate for the risk taken. Compared to its peers, DRREDDY underperformed DIVISLAB and HINDUNILVR, but outperformed SUNPHARMA. Overall, the stock was moderately risky this week.

[Volatility: 11.73%]